News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Alfresa Pharma Corporation And Tanabe Seiyaku Company To Collaborate In Development And Sales Of Narcolepsy Drug Modafinil


4/5/2006 11:26:56 AM

Tokyo, Apr 5, 2006 (JCN) - Alfresa Pharma, a wholly owned subsidiary of Alfresa Holdings, has signed an agreement with Tanabe Seiyaku on modafinil, an agent for treating narcolepsy. Upon receiving approval, the two companies will co-promote the agent under the trade name of Modiodal in Japan. Further, they will proceed with research on the agent with the aim of expanding indications including obstructive sleep apnea syndrome and pediatric ADHD.


Read at JCN Newswire


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES